9WN-10664-34491
4 vaccinations
2 coded responses
41 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 775 / TX
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Dose 1 — Pfizer-BioNTech
-
2021-03-29
Dose 2 — Pfizer-BioNTech
-
2021-03-30
Registered in v-safe
-
2021-03-30
Survey response — days 1–6 daily, dose 2MedDRA: Sensitive skin — Feeling: Poor · Site: Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Skin sensitivityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-01
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-27
- 2021-05-03
- 2021-05-12
- 2021-06-28
- 2021-09-29
-
2021-11-22
Dose 3 — Pfizer-BioNTech
-
2021-11-23
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-11-27
-
2021-11-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-29
- 2021-12-06
- 2021-12-13
- 2021-12-20
- 2021-12-27
- 2022-01-03
- 2022-02-21
- 2022-05-23
-
2022-10-21
Dose 4 — Pfizer-BioNTech
-
2022-10-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-23
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Redness, Swelling, Itching · ChillsAdult check-in
-
2022-10-24
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Redness, Swelling · ChillsAdult check-in
-
2022-10-25
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
-
2022-10-26
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2022-10-27
- 2022-10-28
- 2022-11-06
- 2022-11-13
- 2022-11-20
- 2022-11-25
- 2022-12-02
-
2023-01-20
Survey response — 3 months, dose 4MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-01-20
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professional1 call case(s)
-
2023-01-24
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech | |
| 3 | 2021-11-22 | Pfizer-BioNTech | No |
| 4 | 2022-10-21 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Skin sensitivity
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Sensitive skin | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release